Masters to expand access to Chagas disease treatment
This article was originally published in Scrip
Executive Summary
The UK firm Masters has signed an exclusive deal with Brazil's state-owned Pharmaceutical Laboratory of Pernambuco (Lafepe) for the global distribution of benznidazole for the treatment of Chagas disease.